Bucchi L, Falcini F, Schincaglia P, Desiderio F, Bondi A, Farneti M, Casadei Giunchi D, Serafini M, Canuti D, Caprara L, Sabbadini F, Monari F, Sassoli P
Romagna Cancer Registry, Medical Oncology Department, Luigi Pierantoni Hospital, 47100 Forlì, Italy.
Eur J Cancer Prev. 2003 Jun;12(3):223-8. doi: 10.1097/00008469-200306000-00009.
The availability of published data from organized cervical screening programmes in southern Europe is scant. In the Italian area of Romagna, a first round of organized screening (based on a 3-yearly Pap smear for women aged 25-64 years) was initiated between December 1995 and January 1997 and was completed in an average of 42 months (range 36-48 months). The target population included 305 478 women. Of these, 253 949 were eligible and received a personal letter of invitation. Age-specific screening performance indicators were calculated according to standard methods. The response rate within 6 months of invitation was 49.1% (n=124 621). The total participation rate including women who presented later was 61.7% (n=156 735). The recall rate was 35.2 per 1000 of participants (n=5514). Positive cytology results were distributed as follows: atypical squamous cells of un-determined significance/atypical glandular cells of undetermined significance (ASCUS/AGUS) 40.1%, low-grade squamous intraepithelial neoplasia (LGSIL) 48.6%, high-grade squamous intraepithelial neoplasia (HGSIL) 10.7% and carcinoma 0.7%. Compliance to colposcopy follow-up was 93.4% (n=5149). The biopsy rate was 52.4% (n=2696) of patients undergoing colposcopy. The detection rate was 4.5 per 1000 of participants (n=707) for CIN2-3 and 0.5 (n=75) for invasive carcinoma. The proportion of microinvasive carcinomas was 36.0% (n=27). The positive predictive value for CIN2-3/carcinoma was 5.8% for the cytology reports of ASCUS/AGUS, 7.6% for those of LGSIL, 76.5% for those of HGSIL, and 100.0% for those of carcinoma (80.4% for combined HGSIL/carcinoma). The ratio of observed to expected (or prevalent to incident) cases of invasive carcinoma was 2.35 (95% confidence interval (CI) 1.85-2.95). In conclusion, most early results of the programme were compatible with an acceptable performance.
南欧有组织的宫颈筛查项目的公开数据很少。在意大利的罗马涅地区,1995年12月至1997年1月启动了第一轮有组织的筛查(针对25 - 64岁女性每3年进行一次巴氏涂片检查),平均在42个月内完成(范围为36 - 48个月)。目标人群包括305478名女性。其中,253949名符合条件并收到了个人邀请信。根据标准方法计算了特定年龄的筛查性能指标。邀请后6个月内的响应率为49.1%(n = 124621)。包括后来就诊的女性在内的总参与率为61.7%(n = 156735)。召回率为每1000名参与者35.2例(n = 5514)。阳性细胞学结果分布如下:意义不明确的非典型鳞状细胞/意义不明确的非典型腺细胞(ASCUS/AGUS)40.1%,低级别鳞状上皮内瘤变(LGSIL)48.6%,高级别鳞状上皮内瘤变(HGSIL)10.7%,癌0.7%。阴道镜检查随访的依从率为93.4%(n = 5149)。接受阴道镜检查的患者活检率为52.4%(n = 2696)。CIN2 - 3的检出率为每1000名参与者4.5例(n = 707),浸润癌的检出率为0.5例(n = 75)。微浸润癌的比例为36.0%(n = 27)。ASCUS/AGUS细胞学报告中CIN2 - 3/癌的阳性预测值为5.8%,LGSIL的为7.